Results 21 to 30 of about 42,297 (231)

Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag?

open access: yesTurkish Journal of Hematology, 2022
Objective: Eltrombopag remains a prominent option in the treatment of steroid-dependent or steroid-refractory immune thrombocytopenia (ITP) patients. Unfortunately, not all patients respond to eltrombopag.
Mehmet Baysal   +4 more
doaj   +1 more source

Intracellular and circulating neuronal antinuclear antibodies in human epilepsy

open access: yesNeurobiology of Disease, 2013
There are overwhelming data supporting the inflammatory origin of some epilepsies (e.g., Rasmussen's encephalitis and limbic encephalitis). Inflammatory epilepsies with an autoimmune component are characterized by autoantibodies against membrane-bound ...
Philip H. Iffland, II   +8 more
doaj   +1 more source

Antinuclear Antibodies in Patients with Psoriatic Arthritis Treated or Not with Biologics. [PDF]

open access: yesPLoS ONE, 2015
With the emergence of biotherapies, accurate diagnosis in early arthritis is needed. At this time, there is no biological marker of psoriatic arthritis.To test whether antinuclear antibodies (ANA) can be used as a diagnostic tool in psoriatic arthritis ...
Florent Silvy   +8 more
doaj   +1 more source

Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited

open access: yesDiagnostic Pathology, 2009
It has been more than 50 years since antinuclear antibodies were first discovered and found to be associated with connective tissue diseases. Since then different methods have been described and used for their detection or confirmation.
Minz Ranjana   +2 more
doaj   +1 more source

Immunology markers that can be predictive for the diagnosis of juvenile idiopathic arthritis

open access: yesJournal of Laboratory Medicine, 2020
This study aimed to investigate the implications of antinuclear antibodies (ANAs) in juvenile idiopathic arthritis (JIA), the association with uveitis and the favorable evolution of the disease.
Sur Lucia M.   +9 more
doaj   +1 more source

Clinical diagnoses associated with a positive antinuclear antibody test in patients with and without autoimmune disease

open access: yesBMC Rheumatology, 2023
Background Antinuclear antibodies (ANA) are antibodies present in several autoimmune disorders. However, a large proportion of the general population (20%) also have a positive test; very few of these individuals will develop an autoimmune disease, and ...
Jacy T. Zanussi   +8 more
doaj   +1 more source

Antinuclear antibodies in systemic sclerosis associated with increased risk of malignancy

open access: yesPrzegląd Dermatologiczny, 2018
Patients with systemic sclerosis are at 1.5–5-fold increased risk of developing malignant diseases. It has been shown that some types of antinuclear antibodies associated with systemic sclerosis may have predictive value for development of malignant ...
Anna Stochmal   +3 more
doaj   +1 more source

Catastrophic Antiphospholipid Syndrome after Orthotopic Liver Transplant

open access: yesCase Reports in Transplantation, 2022
Background. Catastrophic antiphospholipid syndrome (CAPS) is an autoimmune thrombogenic disorder of small and large vessels caused by autoantibodies against phospholipids and phospholipid-binding proteins.
R. Okeke   +8 more
doaj   +1 more source

Autoantibody profiles and their association with blood eosinophils in asthma and COPD

open access: yesAllergology International, 2017
Background: Autoimmune involvement in the pathogenesis of asthma and chronic obstructive pulmonary disease (COPD) has been proposed, and autoantibodies are a hallmark of autoimmunity.
Koji Tamai   +10 more
doaj   +1 more source

Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

open access: yesArthritis Care &Research, EarlyView.
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy